Literature DB >> 23650419

miR-155 in acute myeloid leukemia: not merely a prognostic marker?

Cailin E Joyce1, Carl D Novina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23650419     DOI： 10.1200/JCO.2012.48.3180

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence.

Authors:  Sadaf Atarod; Mohammed Mahid Ahmed; Clare Lendrem; Kim Frances Pearce; Wei Cope; Jean Norden; Xiao-Nong Wang; Matthew Collin; Anne Mary Dickinson
Journal:  Front Immunol       Date:  2016-03-08       Impact factor: 7.561

2.  [Association of MiR-155 expression with prognosis in resected 
stage III non-small cell lung cancer].

Authors:  Yi Gao; Shengling Fu; Wenyang Jiang; Binfeng Li; Yitao Tian; Xiangning Fu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-05

3.  Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.

Authors:  Marzia Dolcino; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Elisa Tinazzi; Claudio Lunardi; Antonio Puccetti
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

4.  Transforming growth factor-β1-induced podocyte injury is associated with increased microRNA-155 expression, enhanced inflammatory responses and MAPK pathway activation.

Authors:  Xintong Zheng; Qiuhong Zhong; Xu Lin; Xianjun Gu; Xiaoyan Ling; Zhao Liang; Qing Qin; Xiuri Du
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.